NARI Forecast


Bullish Case: Inari Medical has strong institutional support, promising new product launches, and AI forecasted +1.69% potential growth.


Bearish Case: Legal challenges, competitive pressures, and insider selling signal potential internal issues, with high implied volatility reflecting market uncertainty.


Potential Outcomes:

1. FDA approval of new devices: 25%.

2. Competitive pressures intensify: 35%.

3. Earnings beat: 30%.

4. Continuation of legal challenges: 40%.


Trading Oracle: Engage in long volatility debit spreads targeting September expiry. This capitalizes on potential positive news from FDA and earnings, against a backdrop of high volatility. This strategy offers a favorable risk-reward setup.


July 13, 2024


Inari Medical Forecast

NARI      Inari Medical











Correlated Assets

Assets that tend to move strongly with NARI



VFC Forecast + Options Trading Strategies   VFC  VF (0.81)


LI Forecast + Options Trading Strategies   LI  Li Auto (0.58)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.5)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (-0.69)



Uncorrelated Assets

Assets with little price relationship to NARI



XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.5)


LI Forecast + Options Trading Strategies   LI  Li Auto (0.58)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (-0.69)


VFC Forecast + Options Trading Strategies   VFC  VF (0.81)



Anticorrelated Assets

Assets that tend to move strongly against NARI



VFC Forecast + Options Trading Strategies   VFC  VF (0.81)


LI Forecast + Options Trading Strategies   LI  Li Auto (0.58)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.5)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (-0.69)





Become a more profitable investor with AI optimized trading strategies






×

Chat with NARI


 Ask any question about NARI!